Medicines and Related Substances Act, 1965
R 385
Banks Act, 1990 (Act No. 94 of 1990)RegulationsRegulations relating to BanksChapter II : Financial, Risk-based and other related Returns and Instructions, Directives and Interpretations relating to the completion thereof24. Credit risk: quarterly returnDirective and interpretations for completion of the quarterly return concerning credit risk (Form BA 210)Subregulation (1) to (3) |
(1) | The content of the return is confidential and not available for inspection by the public. |
(2) | The purpose of the return is to obtain selected information in respect of— |
(a) | credit risk mitigation; |
(b) | restructured credit exposure; |
(c) | credit risk classification and related credit impairment or allowance for credit impairment raised by a bank that adopted the standardised approach for the measurement of the bank's exposure to credit risk; |
(d) | credit concentration risk; |
(e) | large exposure to a person; |
(f) | exposures included on a watch list of the reporting bank in order to duly manage the said exposures due to particular circumstances that warrant more than normal attention from the reporting bank's senior management; |
(g) | connected lending or lending to a related person. |
(3) | Unless specifically otherwise provided or specified in writing by the Registrar, a bank shall in all cases other than the items specified below complete the form BA 210 based on the outstanding amount at the end of the reporting month, provided that in respect of the items specified below and any related eligible credit risk mitigation in respect of that specified item, instead of the outstanding amount at the end of the reporting month, the bank shall report the average daily balance of the said specified item and the average daily balance related to any eligible credit risk mitigation in respect of that specified item in respect of the reporting month. |
(a) | Any credit card or overdraft facility. |
(b) | Any corporate exposure related to working capital or an overdraft facility. |
(c) | Any SME working capital facility or overdraft. |
(d) | Any money market exposure to a financial institution. |
(e) | Any call or overnight loan. |